Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair thinning on Mounjaro is real, but it is almost never caused by the medicine itself. The most common reason is telogen effluvium — a temporary, stress-related shedding that follows rapid weight loss, not a direct side effect of tirzepatide. Most people who notice it find the shedding slows and stops on its own within a few months. These are prescription-only medicines assessed by a clinical prescriber, so any concerns about hair changes are worth raising at your next review.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people notice more hair in the shower tray a few months into treatment, the instinct is to blame the injection. That reaction is understandable. But the evidence points elsewhere. Telogen effluvium is a well-documented response to any period of significant physical or metabolic stress (surgery, illness, crash dieting, rapid weight loss) and it happens because a large number of hairs shift into a resting phase at the same time, then shed together six to twelve weeks later. The timing makes it look like the medicine is the cause, when really the trigger was the weight change itself.
The NHS tirzepatide medicines page does list alopecia as an uncommon side effect, but this observation came largely from the SURPASS diabetes trials, where participants were not losing weight at the same rate as in the weight-management programme. Separating a direct drug effect from the physiological impact of losing fifteen to twenty percent of body weight in under a year is genuinely difficult, and the current evidence does not support the idea that tirzepatide damages hair follicles directly.
If you are experiencing hair changes during Mounjaro treatment, knowing the likely cause tends to reduce anxiety considerably, which is itself useful, because psychological stress can prolong the shedding phase.
Mounjaro reduces appetite meaningfully. That is the point. But a sharp drop in food intake can, unless actively managed, mean a drop in the nutrients hair follicles depend on most: protein, iron, zinc and B vitamins. Hair is almost entirely protein. When the body is in an energy deficit and protein intake is low, it treats hair growth as non-essential and redirects resources elsewhere. The result can be shedding that is heavier or longer-lasting than it would otherwise be.
A practical habit worth building: run a rough check on your protein intake once a week. Aim for roughly 1.2 to 1.6 grams per kilogram of body weight per day, spread across meals rather than loaded into one. Greek yoghurt, eggs, fish, chicken and pulses are all practical choices that do not require large portions to deliver a meaningful amount. Your prescriber or a registered dietitian can give you a target that fits your specific plan.
Iron deficiency is also common in people losing weight quickly, particularly in women. A simple full blood count from your GP can pick this up. It takes about three minutes to request. If ferritin is low, that is worth addressing alongside everything else, because iron deficiency alone can cause noticeable thinning that will not resolve until levels recover. You can read more about the connection between losing hair on Mounjaro and how nutrition fits into the picture.
For the majority of people experiencing telogen effluvium alongside weight loss, shedding peaks roughly three to four months after the trigger and then gradually slows. By six months, most people notice the worst is behind them. Regrowth (shorter, slightly finer hairs at the scalp) tends to appear around the same time the shedding eases.
That pattern is reassuring, but it should not lead anyone to dismiss changes that fall outside it. A few situations warrant a conversation rather than a wait-and-see approach. If shedding is severe rather than noticeable, if it began before any significant weight loss, if it is patchy rather than diffuse, or if it has continued beyond six months without any sign of slowing, those are reasons to speak with a prescriber or your GP. Conditions including thyroid dysfunction and alopecia areata can coincide with or be unmasked by a period of weight change, and they require their own assessment.
Thinning hair on Mounjaro is also worth raising at any clinical review, because your prescriber can consider whether titration pace, nutritional support or a blood test referral would help. Our clinical team reviews every patient's progress, not just their weight. If you have questions about how the medicine affects you day to day, the FAQs page covers some of the most common ones, and the contact page reaches our aftercare team seven days a week.
It is worth holding two things at the same time. Hair thinning is genuinely distressing. It is also, in most cases, temporary and manageable. The clinical trials that support Mounjaro's use in weight management (large, long-term studies involving thousands of adults) did not show hair loss as a prominent or frequent finding in the weight-management population, which is a meaningful data point even if it is not a guarantee for any individual.
The broader question of whether the benefits of treatment outweigh the side effects is one for you and your prescriber, not a forum thread. If you are thinking about the cost of Mounjaro alongside the clinical picture, or want to understand the full range of weight-loss treatment options available through a regulated pharmacy, both of those are reasonable starting points. The question of whether hair loss is inevitable on this treatment has a more nuanced answer than most online sources suggest, and it is worth reading carefully before drawing conclusions. For a wider grounding in tirzepatide as a medicine, including how it works and what the trial evidence shows, that overview covers the detail.
If hair changes are causing you concern, speaking to a prescriber is the most direct route to a clear answer. Speak to our prescribers, they review the full picture, not just one symptom.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.